<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10</volume><submitter>Shahid S</submitter><pubmed_abstract>Leukocyte adhesion deficiency-III (LAD3) is an extremely rare primary immunodeficiency disorder, transmitted with autosomal-recessive inheritance. It is caused by genetic alteration in the &lt;i>FERMT3&lt;/i> gene, which leads to abnormal expression of kindlin-3. This cytoplasmic protein is highly expressed in leukocytes and platelets, and acts as an important regulator of integrin activation. LAD3 has features like bleeding syndrome of Glanzmann-type and leukocyte adhesion deficiency. &lt;i>FERMT3&lt;/i> mutation(s) have not been well characterized in Pakistani patients with LAD3. In this study, an infant and his family of Pakistani origin, presenting with clinical features of LAD, were investigated to determine the underlying genetic defect. Targeted next generation sequencing (TGS) and Sanger seque</pubmed_abstract><journal>Frontiers in genetics</journal><pagination>360</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6491447</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A Novel Nonsense Mutation in &lt;i>FERMT3&lt;/i> Causes LAD-III in a Pakistani Family.</pubmed_title><pmcid>PMC6491447</pmcid><pubmed_authors>Shahid S</pubmed_authors><pubmed_authors>Ahmed S</pubmed_authors><pubmed_authors>Siddiqui S</pubmed_authors><pubmed_authors>Malik S</pubmed_authors><pubmed_authors>Zaidi S</pubmed_authors><pubmed_authors>Abid A</pubmed_authors><pubmed_authors>Shamsi T</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Novel Nonsense Mutation in &lt;i>FERMT3&lt;/i> Causes LAD-III in a Pakistani Family.</name><description>Leukocyte adhesion deficiency-III (LAD3) is an extremely rare primary immunodeficiency disorder, transmitted with autosomal-recessive inheritance. It is caused by genetic alteration in the &lt;i>FERMT3&lt;/i> gene, which leads to abnormal expression of kindlin-3. This cytoplasmic protein is highly expressed in leukocytes and platelets, and acts as an important regulator of integrin activation. LAD3 has features like bleeding syndrome of Glanzmann-type and leukocyte adhesion deficiency. &lt;i>FERMT3&lt;/i> mutation(s) have not been well characterized in Pakistani patients with LAD3. In this study, an infant and his family of Pakistani origin, presenting with clinical features of LAD, were investigated to determine the underlying genetic defect. Targeted next generation sequencing (TGS) and Sanger seque</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019</publication><modification>2025-04-26T18:22:29.802Z</modification><creation>2019-06-06T23:09:26Z</creation></dates><accession>S-EPMC6491447</accession><cross_references><pubmed>31068971</pubmed><doi>10.3389/fgene.2019.00360</doi></cross_references></HashMap>